Regulatory Toxicology and Pharmacology
Abbreviated title (ISO 4) | Regul. Toxicol. Pharmacol. |
|---|---|
| Discipline | Toxicology and Pharmacology |
| Language | English |
| Edited by | Gio B. Gori |
| Publication details | |
| Publisher |
Elsevier on behalf of the International Society of Toxicology & Pharmacology |
Publication history | 1981–present |
| Frequency | Monthly |
| 2.031 | |
| Indexing | |
| ISSN |
0273-2300 |
| LCCN | 81646304 |
| CODEN | RTOPDW |
| OCLC no. | 485750423 |
| Links | |
Regulatory Toxicology and Pharmacology is a monthly peer-reviewed scientific journal which covers legal aspects of toxicological and pharmacological regulations. It is published by Elsevier on behalf of the International Society of Regulatory Toxicology & Pharmacology. The current editor-in-chief is Gio Batta Gori. The journal is financed in part by the tobacco, pharmaceutical, and chemical industries.[1]
In 2002, a group of 45 academics wrote a letter accusing the journal of a concealed pro-industry bias, a possible lack of full and independent peer review, and a failure to disclose conflicts of interest, citing a case in which Gori was paid $30,000 by the Tobacco Institute to write an article later published in the journal dismissing the health risks of secondhand smoke.[2][3] The letter's coordinator later commented that the journal "reads like an industry trade publication, but it's masked as a peer-reviewed journal" and that it lacked any "credible peer-review process."[4] In response, the journal's publisher implemented a conflict of interest disclosure policy at the journal in January of 2003, shortly before the correspondence was published.[2]
Abstracting and indexing
The journal is abstracted and indexed in EMBASE, EMBiology, and Scopus.
According to the Journal Citation Reports, the journal has a 2014 impact factor of 2.031, ranking it 56th out of 87 journals in the category "Toxicology"[5] and 146th out of 254 journals in the category "Pharmacology & Pharmacy".[6]
References
- ↑ Drope J, Bialous SA, Glantz SA (March 2004). "Tobacco industry efforts to present ventilation as an alternative to smoke-free environments in North America". Tob Control. 13 Suppl 1: i41–7. PMC 1766145
. PMID 14985616. doi:10.1136/tc.2003.004101. - 1 2 Egilman, David, ed. (2003). "Correspondence about Publication Ethics and Regulatory Toxicology and Pharmacology". International Journal of Occupational and Environmental Health. 9 (4): 286–391. doi:10.1179/oeh.2003.9.4.386.
- ↑ Gori, Gio Batta; Mantel, Nathan (August 1991). "Mainstream and environmental tobacco smoke". Regulatory Toxicology and Pharmacology. Elsevier. 14 (1): 88–105. doi:10.1016/0273-2300(91)90054-Y.
- ↑ Guterman, Lila (November 20, 2002). "Scientists Accuse Toxicology Journal of Industry Ties, Urge Disclosure of Conflicts of Interest". Chronicle of Higher Education.
- ↑ "Journals Ranked by Impact: Toxicology". 2014 Journal Citation Reports. Web of Science (Sciences ed.). Thomson Reuters. 2015.
- ↑ "Journals Ranked by Impact: Pharmacology & Pharmacy". 2014 Journal Citation Reports. Web of Science (Sciences ed.). Thomson Reuters. 2015.